Premature Rupture of Membranes

2

Review clinical trials related to Premature Rupture of Membranes. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

I.V Papavrine for Labor Induction in Term PROM

This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo

Participants needed: 110
Trial details
Phase: Phase 4Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Western Galilee Hospital-NahariyaUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

• Singleton pregnancy [+6]

• Multiple gestation [+5]

Status: Not yet recruiting

Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture of Membranes : A French Multicenter Cohort Study

This study looks at how common certain antibiotic-resistant bacteria (called extended-spectrum beta-lactamase-producing Enterobacteriaceae, or E-BLSE) are in pregnant women who experience premature breaking of their water before full term. The goal is to understand how often these bacteria are found, how long they stay, and what factors increase the risk of carrying them. This information will help doctors choose the best antibiotics to protect both the mother and baby from infections during and after pregnancy. The study follows women from the time of their membrane rupture until delivery, collecting samples to track the bacteria over time.

Participants needed: 250
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Centre Hospitalier de Saint-DenisUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

Pregnant women aged over 18 years [+2]

No available microbiological sample [+2]